Quote:

---

Are we able to go straight to a Phase 3 trial in MASH based on our previous Phase 2 study with the design of the P3 trial being based around the murine studies or do we have to start over at P2?

---

With any luck, we won't be doing any MASH trials at all. We can just sit back and admire the efficacy of Leron in fibrosis from afar, while we work on cancers.